Awagin Consulting
VC Fund
Tokushima, Japan
Awagin Consulting is a VC fund in Tokushima focused on Health Care and Biotechnology. Awagin Consulting provides management improvement support consulting services.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Awagin Consulting invests in
Stages Awagin Consulting invests in
Countries Awagin Consulting invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Business Information Systems 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Setsuro Tech
|
Seturotech is a biotechnology venture company established on February 22, 2017 by Tatsuya Takemoto (PI: Principal Investigator) of the University of Tokushima as a venture from Tokushima University. In 2015, Takemoto and Masakazu Hashimoto (Osaka University) developed a simple and highly efficient method for producing genetically modified(genome-edited) mice using CRISPR / Cas9, and filed a patent application for the technology. The technology is called fertilized egg electroporation (GEEP method), a technology that introduces molecules required for genome editing by CRISPR into fertilized eggs at high throughput by the power of electricity (electroporation). Using this technology, Seturotech will start from the production and sale of genetically modified mice, and will become a fundamental company providing all genetically modified animals, anticipating the future use of genetically modified animals in industry. | $4.3M / Series A / Jun 02, 2020 |
Co-Investors
A-Five
1 deal together
Miraidoa
1 deal together
Kagawa Bank
1 deal together
Kitaoka Group
1 deal together
Nakayama
1 deal together
SBI Investment
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Awagin Consulting invest in?
Awagin Consulting invests primarily in Health Care, Biotechnology and Business Information Systems startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Awagin Consulting last invest?
The most recent investment recorded for Awagin Consulting closed in Jun 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
